Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho GTPases are a subfamily of the Ras superfamily of small GTPases that act as molecular switches cycling between an inactive GDP-bound state and an active GTP-bound state. They regulate actin cytoskeletal organization, cell migration, adhesion, morphology, cell cycle progression, secretion, pinocytosis/endocytosis, transcriptional activation, and DNA synthesis initiation. Dysregulation is implicated in cancer, making them potential anti-cancer drug targets.
Inhibition of Rho GTPase activity; disruption of downstream signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho GTP-binding Protein (Rho GTPase).